Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn M Matrisian

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Plos One|November 19, 2011
Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to boneSwati Biswas, Jeffry S Nyman, JoAnn Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational researchMartin A Cheever, James P Allison, Andrea S Ferris, et al.
Cancer Research|May 1, 2010
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agentsMd Jashim Uddin, Brenda C Crews, Anna L Blobaum, et al.
Circulation|June 14, 2006
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarctionMerry L Lindsey, G Patricia Escobar, Rupak Mukherjee, et al.
The American Journal of Pathology|March 25, 2004
Proteases, extracellular matrix, and cancer: a workshop of the path B study sectionYves A DeClerck, Arthur M Mercurio, M Sharon Stack, et al.
Cancer Cell|May 17, 2005
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKLConor C Lynch, Atsuya Hikosaka, Heath B Acuff, et al.
Neurotoxicology|March 4, 2015
New tools for the quantitative assessment of prodrug delivery and neurotoxicityLynn E Samuelson, Randy L Scherer, Michael N VanSaun, et al.
Molecular Cancer Research : MCR|May 19, 2007
Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironmentDonald R Schwartz, Kamiar Moin, Bin Yao, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Plos One|November 19, 2011
Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to boneSwati Biswas, Jeffry S Nyman, JoAnn Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational researchMartin A Cheever, James P Allison, Andrea S Ferris, et al.
Cancer Research|May 1, 2010
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agentsMd Jashim Uddin, Brenda C Crews, Anna L Blobaum, et al.
Circulation|June 14, 2006
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarctionMerry L Lindsey, G Patricia Escobar, Rupak Mukherjee, et al.
The American Journal of Pathology|March 25, 2004
Proteases, extracellular matrix, and cancer: a workshop of the path B study sectionYves A DeClerck, Arthur M Mercurio, M Sharon Stack, et al.
Cancer Cell|May 17, 2005
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKLConor C Lynch, Atsuya Hikosaka, Heath B Acuff, et al.
Neurotoxicology|March 4, 2015
New tools for the quantitative assessment of prodrug delivery and neurotoxicityLynn E Samuelson, Randy L Scherer, Michael N VanSaun, et al.
Molecular Cancer Research : MCR|May 19, 2007
Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironmentDonald R Schwartz, Kamiar Moin, Bin Yao, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
Pageof 12